×
DermTech Net Profit Margin 2017-2024 | DMTKQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
DermTech net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
DermTech Net Profit Margin 2017-2024 | DMTKQ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
DermTech net profit margin from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Elevance Health (ELV)
$96B
Cencora (COR)
$46.2B
DiDi Global (DIDIY)
$23.8B
ICON (ICLR)
$18.2B
Natera (NTRA)
$15.4B
Avantor (AVTR)
$15.2B
Revvity (RVTY)
$14.9B
Viatris (VTRS)
$13.9B
BioMerieux (BMXMF)
$12.8B
Solventum (SOLV)
$12.5B
CochLear (CHEOY)
$12.3B
Medpace Holdings (MEDP)
$9.9B
Charles River Laboratories (CRL)
$9.3B
Sonic Healthcare (SKHHY)
$8.4B
Doximity (DOCS)
$7.9B
HealthEquity (HQY)
$7.5B
Bausch + Lomb (BLCO)
$7.2B
PACS (PACS)
$6.5B
Life Times (LTH)
$4.7B
Organon (OGN)
$4.7B
Sotera Health (SHC)
$4.5B
Surgery Partners (SGRY)
$3.7B
BrightSpring Health Services (BTSG)
$3B
Concentras Parent (CON)
$2.5B
Ardent Health Partners (ARDT)
$2.5B
Alignment Healthcare (ALHC)
$2.5B
GoodRx Holdings (GDRX)
$2.3B
GeneDx Holdings (WGS)
$2.1B
Premier (PINC)
$2B
Ryman Healthcare (RYHTY)
$1.9B